Allen Albright

Allen Albright, PhD, currently serves as the Senior Vice President of Regulatory Affairs at MBrace Therapeutics, a role held since April 2023. Prior to this position, Allen accumulated extensive experience in the biotechnology and pharmaceutical sectors, holding significant roles such as Vice President of Regulatory Affairs & Quality Assurance at Mirati Therapeutics and Anadys Pharmaceuticals, and Senior Director of Regulatory Affairs at Halozyme Therapeutics. Allen has a robust background in guiding drug development processes, particularly in oncology and biopharmaceuticals, and possesses a strong educational foundation with a PhD in Microbiology & Immunology from Uniformed Services University and postdoctoral training in Molecular Biology from The Johns Hopkins University School of Medicine.